Cocoa with exercise to boost walking and strength in older adults
Official title: Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial
Run by University of Alabama at Birmingham · NCT07161726 · Data updated 2026-11-12
This study will test whether taking a cocoa supplement high in (-)-epicatechin together with regular aerobic and resistance exercise helps older adults with slow walking speed improve walking and muscle strength more than exercise alone.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 55 Years and up |
| Sex | All |
| Enrollment | 36 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Status | Recruiting |
| Started | April 21, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT07161726 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 55 years or older with slow walking speed (<1.0 m/s) who can participate in supervised aerobic and resistance training and agree to randomization and study procedures.
✕Probably not a fit
People already taking flavanol or cocoa supplements, currently enrolled in supervised exercise programs, or with medical contraindications to exercise (for example severe cardiac disease) are unlikely to be eligible or to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized Phase 1/2 study enrolls adults aged 55 and older with slow walking speed (<1.0 m/s) and compares structured aerobic plus resistance training combined with an (-)-epicatechin–rich cocoa supplement versus the same exercise program with a placebo. Participants follow supervised exercise sessions and undergo functional testing of walking performance and muscle strength, with optional muscle biopsy for mechanistic studies. The trial targets mitochondrial function and reactive oxygen species pathways as potential biological reasons some people do not fully respond to exercise alone. The study is single-site at the University of Alabama at Birmingham.
Why it matters
Potential benefit: If successful, adding an (-)-epicatechin–rich cocoa supplement to exercise could produce greater improvements in walking speed and muscle strength than exercise by itself.
How similar studies have gone: Animal studies and small human studies have shown (-)-epicatechin–rich cocoa can improve mitochondrial function, walking performance, and strength, and combining it with exercise helped mice, but larger randomized trials in older adults remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 55 years and older * Slow walking speed of \< 1m/s * Willingness to be randomized to either treatment group * Willingness to participate in all study procedures (muscle biopsy will be optional) Exclusion Criteria: * Failure to provide informed consent; * Regular consumption of flavanol and/or cocoa supplements * Current involvement in supervised rehabilitation/exercise training program * Absolute contraindication(s) to exercise training according to American College of Sports Medicine guidelines \[17\] * Daytime average of systolic blood pressure ≥ 180/100mm Hg. * Refusal to stop blood thinners such as baby aspirin dose. * Peripheral vascular disease; peripheral neuropathy; retinopathy * Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina; * Myocardial infarction or stroke within past year * Significant cognitive impairment, including known dementia diagnosis or a Mini-Mental State Examination exam score \< 24 * Progressive, degenerative neurologic disease, e.g., Parkinson's Disease, multiple sclerosis; * Severe rheumatologic or orthopedic diseases, e.g., awaiting joint replacement, active inflammatory disease; * Severe pulmonary disease, requiring either steroid pills or injections or the use of supplemental oxygen; * Hip fracture, hip or knee replacement, or spinal surgery within past 4 months; * Other significant co-morbid conditions that would impair ability to participate in the exercise-based intervention * Simultaneous participation in another interventional trial
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting
Study contacts
- Principal investigator: Robert T Mankowski, PhD — University of Alabama at Birmingham
- Study coordinator: Robert T Mankowski, PhD
- Email: rmankowski@uabmc.edu
- Phone: 205-996-3006
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How biological aging affects response to strength (resistance) training in older adults
This project will test whether biological signs of aging explain why some people 65 and older get more benefit from progressive resistance (strength) training than others.
-
Personalized home brain stimulation to help thinking and walking in older adults with motoric cognitive risk
This trial tests whether personalized, home-based transcranial direct current stimulation (tDCS) can improve thinking and walking in people aged 65–90 who have motoric cognitive risk.
-
Sleep Better, Live Better: a 12-week coaching program to help adults improve sleep and heart-brain health
This trial tests a 12-week, telephone- and text-based sleep coaching program for adults 25–65 with short sleep and higher cardiometabolic risk to see if it improves sleep and related behaviors.
-
Community health worker support to lower blood pressure after pregnancy with high blood pressure
Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
See if deep brain stimulation for Parkinson's changes thinking and movement and affects fall risk
This pilot study tests whether deep brain stimulation in people with Parkinson’s changes thinking or movement and whether those changes relate to how often they fall.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.